Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 1/20 | 0.49 |
| ▸ | HTR7 | P34969 | 4/20 | 0.48 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23092046 | 0.88 | KCNN4 (0.43) | KCNN4HTR7ADRB2EGFRPTPN1 | |
| SCHEMBL3185351 | 0.87 | CA12 (0.48) | KCNN4CA12CA1CA2CA4 | |
| SCHEMBL30741239 | 0.87 | CA12 (0.48) | KCNN4CA12CA1CA2CA4 | |
| SCHEMBL30741241 | 0.87 | CA12 (0.48) | KCNN4CA12CA1CA2CA4 | |
| SCHEMBL5840781 | 0.87 | ADRB2 (0.60) | HTR7ADRB2EGFRKDM4ETP53 | |
| SCHEMBL30604339 | 0.84 | KCNN4 (0.46) | KCNN4HTR7CA12CA1CA2 | |
| SCHEMBL3825898 | 0.84 | ALDH1A1 (0.50) | KCNN4HTR7ADRB2EGFRKDM4E | |
| SCHEMBL10453409 | 0.81 | KCNN4 (0.39) | KCNN4HTR7ADRB2EGFRRAB9A | |
| SCHEMBL27504574 | 0.81 | KCNN4 (0.39) | KCNN4HTR7ADRB2EGFRKDM4E | |
| SCHEMBL31360728 | 0.81 | CA1 (0.62) | CA12CA1CA2CA4CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9950979-B2 | Method for producing asymmetrical biphenols using selenium dioxide | EVONIK DEGUSSA GMBH (DE) | 2018-04-24 | — | — | US | disclosed |
| US-9950979-B2 | Method for producing asymmetrical biphenols using selenium dioxide | EVONIK DEGUSSA GMBH (DE) | 2018-04-24 | — | — | US | disclosed |
| US-20170204031-A1 | METHOD FOR PRODUCING ASYMMETRICAL BIPHENOLS USING SELENIUM DIOXIDE | EVONIK DEGUSSA GMBH (DE) | 2017-07-20 | — | — | US | disclosed |
| US-20170204031-A1 | METHOD FOR PRODUCING ASYMMETRICAL BIPHENOLS USING SELENIUM DIOXIDE | EVONIK DEGUSSA GMBH (DE) | 2017-07-20 | — | — | US | disclosed |
| US-7151070-B2 | Chiral catalyst, process for preparing the same and its use in the oxidate coupling of naphthols | CHENGDU INSTITUTE OF ORGANIC CHEMISTRY CHINESE ACADEMY OF SCIENCES (CN) | 2006-12-19 | — | — | US | disclosed |
| US-20050256345-A1 | Chiral catalyst, process for preparing the same and its use in the oxidate coupling of naphthols | CHENGDU INSTITUTE OF ORGANIC CHEMISTRY CHINESE ACADEMY OF SCIENCES (CN) | 2005-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170204031-A1 | METHOD FOR PRODUCING ASYMMETRICAL BIPHENOLS USING SELENIUM DIOXIDE | SELENOI, SCLY, GPX4 | KCNN4 1265/4885HTR7 2195/4885ADRB2 2861/4885 |
| US-20050256345-A1 | Chiral catalyst, process for preparing the same and its use in the oxidate coupling of naphthols | BCAT2, BCAT1, NDUFV2 | KCNN4 3196/4885HTR7 3710/4885ADRB2 1067/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.